Company / R&D Expense
DBV Technologies S.A. R&D Expense History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$116.7M
FY2025
5-year range
$60.2M / $116.7M
FY2021-FY2025
Trend
+30.6%
vs FY2024
Sector context
#130 of 209
Health Care
What the data says
At $117M, DBV Technologies S.A.'s r&d expense ranks #130 of 209 in the Health Care sector. R&D Expense has fluctuated over the past 7 years, ranging from $60M in FY2023 to $117M in FY2025.
Based on SEC 10-K filings.
$117M in FY2025 with a 5-year CAGR of +2.8%.
Improved from $60M to $117M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +15.6%
- 5-Year CAGR
- +2.8%
- 10-Year CAGR
- -
Sector benchmark
#130 of 209 in Health CareTop 62% of 209This company $116.7M Sector average $647.6M
▼
-82.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +2.8%, indicating consistent growth.
- In FY2025, r&d expense increased 30.6% year-over-year.
- Ranks #130 out of 209 companies in the Health Care sector.
- Lowest r&d expense in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -1.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $116.7M | +30.6% |
| FY2024 | $89.3M | +48.4% |
| FY2023 | $60.2M | -20.3% |
| FY2022 | $75.5M | +7.4% |
| FY2021 | $70.3M | -30.8% |
| FY2020 | $101.6M | -11.7% |
| FY2019 | $115.1M | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026